Physician profile
Jonathan Tiu
NPI 1659767838
$1,079.20
in general payments reported to CMS, 2019-2025
16 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.44 · 2024: $820 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,012.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.50 | 2021-2025 | |
| Sk Life Science, INC. | $147.01 | 2024 | |
| Medtronic, INC. | $143.35 | 2024 | Synchromedii |
| Microtransponder, INC. | $142.95 | 2024 | |
| Celgene Corporation | $55.79 | 2024-2025 | Zeposia |
| Springworks Therapeutics, INC. | $38.39 | 2025 | Gomekli |
| Pfizer INC. | $37.95 | 2024 | |
| Lundbeck LLC | $30.07 | 2024 | Vyepti |
| Neurocrine Biosciences, INC. | $29.83 | 2024 | Ingrezza |
| Philips North America LLC | $20.88 | 2024 | (Ak6) Vest Therapy |
| Biogen, INC. | $18.22 | 2025 | Leqembi |
| Astrazeneca Pharmaceuticals Lp | $17.00 | 2024 | Andexxa |
| Teva Pharmaceuticals USA, INC. | $16.84 | 2024 | Ajovy |
| Kyowa Kirin, INC. | $16.26 | 2024 | Nourianz |
| Amneal Pharmaceuticals LLC | $16.26 | 2024 | Rytary |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $14.90 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Tiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.